You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 29, 2024

PROAIR DIGIHALER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Proair Digihaler patents expire, and when can generic versions of Proair Digihaler launch?

Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. There are twenty-one patents protecting this drug.

This drug has three hundred and forty-three patent family members in twenty-nine countries.

The generic ingredient in PROAIR DIGIHALER is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proair Digihaler

A generic version of PROAIR DIGIHALER was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.

  Sign Up

Drug patent expirations by year for PROAIR DIGIHALER
Drug Prices for PROAIR DIGIHALER

See drug prices for PROAIR DIGIHALER

Recent Clinical Trials for PROAIR DIGIHALER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesEarly Phase 1
Teva Branded Pharmaceutical Products R&D, Inc.Early Phase 1
University of North Carolina, Chapel HillEarly Phase 1

See all PROAIR DIGIHALER clinical trials

Pharmacology for PROAIR DIGIHALER

US Patents and Regulatory Information for PROAIR DIGIHALER

PROAIR DIGIHALER is protected by twenty-one US patents.

Patents protecting PROAIR DIGIHALER

Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dry powder inhalation apparatus
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Inhaler
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Drug delivery device with electronics and power management
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Inhalation device with integrated electronics
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Drug delivery device with electronics
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Drug delivery device with electronics
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Drug delivery device with electronics
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Drug delivery device with electronics
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dry powder inhalation apparatus
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dry powder inhalation apparatus
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having a bore and shaft arrangement
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROAIR DIGIHALER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PROAIR DIGIHALER

See the table below for patents covering PROAIR DIGIHALER around the world.

Country Patent Number Title Estimated Expiration
Eurasian Patent Organization 037607 МОДУЛЬ МОНИТОРИНГА СОБЛЮДЕНИЯ РЕЖИМА ДЛЯ АКТИВИРУЕМОГО ВДОХОМ ИНГАЛЯТОРА (COMPLIANCE MONITORING MODULE FOR A BREATH-ACTUATED INHALER) ⤷  Sign Up
Australia 2022263489 Drug delivery device with electronics ⤷  Sign Up
South Korea 20030028738 ⤷  Sign Up
Poland 2514466 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.